Iron chelation cancer therapy using hydrophilic block copolymers conjugated with deferoxamine

Cancer cells have high iron requirements due to their rapid growth and proliferation. Iron depletion using iron chelators has a potential in cancer treatment. Previous studies have demonstrated that deferoxamine (DFO) specifically chelates Fe(III) and exhibited antitumor activity in clinical studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Komoto, Kana, Nomoto, Takahiro, El Muttaqien, Sjaikhurrizal, Takemoto, Hiroyasu, Matsui, Makoto, Miura, Yutaka, Nishiyama, Nobuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Drug Discovery and Delivery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780030/
https://www.ncbi.nlm.nih.gov/pubmed/32770631
http://dx.doi.org/10.1111/cas.14607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780030/
https://www.ncbi.nlm.nih.gov/pubmed/32770631
http://dx.doi.org/10.1111/cas.14607

Ejemplares similares